On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…
On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
On Jul. 13, 2020, an emerging virus threatens both wild and pet rabbits in the U.S. The fatal…
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
On Jul. 2, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced a publication in the…
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyï¾’s…
On Jun. 11, 2020, the World Trade Organizationï¾’s (WTO) reported that it was following up with Chinese authorities…
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced thay had discovered…
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
On Jun. 8, 2020, Eli Lilly announced its partner Junshi Biosciences had dosed the first healthy volunteer in…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
On May 6, 2020, Sinovac Biotech announced publication of the preclinical study on animals for its vaccine candidate…
On May 4, 2020, Junshi Biosciences and Eli Lilly announced an agreement to co-develop therapeutic antibodies for the…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 24, 2020, a new study led by researchers at Oxford and Guangdong Centre for Diseases Control…
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
On Apr. 21, 2020, University of Oxford announced that it had successfully obtained re-registration of the T-SPOT.TB test…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
On Apr. 14, 2020, Royal Philips updated its plans to double the production of its hospital ventilators by…
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…